Terms and Conditions
Introduction
Welcome to Kimberlen Clinical Studies. By accessing or using our website, kimberlen.com, you agree to comply with these Terms and Conditions. If you disagree with any part of these terms, please do not use our website. Kimberlen Clinical Studies reserves the right to modify these terms at any time without prior notice. Continued use of the website constitutes your acceptance of the updated terms, so we encourage you to review this page regularly.
Company Information
Kimberlen Clinical Studies
Address: 150 California St Ste 250 San Francisco, CA 94111 United States
Text Messaging Opt-Ins
Program Overview:
By opting into our text messaging service, you will receive updates on clinical trials, products, and any relevant cases.
Message Frequency:
The frequency of messages may vary.
Customer Care:
For assistance, reply HELP to 844-576-2144.
Opt-Out Instructions:
To unsubscribe, reply STOP to 844-576-2144. After doing so, you will no longer receive messages from Kimberlen Clinical Studies.
Carrier Liability:
Carriers are not liable for delayed or undelivered messages.
Message and Data Rates:
Standard message and data rates may apply.
Privacy:
We do not share or sell your phone number to third parties.
Permitted Use
The content provided on the Kimberlen Clinical Studies website is intended for personal, lawful, and non-commercial use related to seeking clinical trial consulting. Use of the website by competitors or other non-consumer third parties is strictly prohibited. Without prior written permission from Kimberlen Clinical Studies, you may not:
- Link to our website from another site.
- Post, transmit, copy, modify, create derivative works from, distribute, or sell any content obtained from our website.
- Engage in systematic retrieval of data or content, including activities mandated by law.
Copyright and Trademarks
All materials on this website, including the Kimberlen Clinical Studies logo, trademarks, and service marks, are owned by Kimberlen Clinical Studies and are protected by international copyright and trademark laws. Unauthorized use of any content is strictly prohibited. © 2024 Kimberlen Clinical Studies. All rights reserved.
Our Products and Services
The information on our website serves as a general reference and may not fully describe the terms, conditions, and exceptions applicable to Kimberlen Clinical Studies’ products and services. Actual coverage is determined by the specific terms and conditions of the Clinical Trial Consulting policies issued. Availability and requirements of products and services may vary depending on your state and individual circumstances. Our products and services are only available in jurisdictions where Kimberlen Clinical Studies is licensed to operate.
Signing Up and Opting-In to the Service
To enroll in our text messaging service, you must provide your mobile phone number and accept these Terms and Conditions. You must be at least 18 years old to enroll. Kimberlen Clinical Studies reserves the right to discontinue the service at any time, with or without notice.
By opting in, you:
- Acknowledge that agreeing to receive messages is not a condition for any purchase.
- Confirm that you are the subscriber or the authorized user of the phone number on a family or business plan.
- Consent to the use of an electronic record to document your opt-in. To request a free paper or email copy of your opt-in or to update our records, please contact us at [email protected].
Message Frequency
The number of messages you receive may vary based on your interaction with our services.
Charges and Carriers
Text messaging and data charges may apply according to your wireless carrier’s service agreement. Kimberlen Clinical Studies is not responsible for any fees associated with using the service. Supported carriers include AT&T, T-Mobile, Sprint, Boost, Virgin Mobile, U.S. Cellular, Cricket, Alltel, Cincinnati Bell, Cellcom, C-Spire, nTelos, MetroPCS, and other smaller regional carriers. Kimberlen Clinical Studies reserves the right to add or remove any carrier from the service at any time without notice. Neither Kimberlen Clinical Studies nor mobile carriers are responsible for any delays, delivery failures, or errors in messages.
Stopping the Service
To opt-out of receiving text messages from Kimberlen Clinical Studies, text STOP to any message you receive from us. This is the only method to unsubscribe. If the service uses a different number, text STOP to that number. Your opt-out request may generate a confirmation text, or you may be asked to clarify which text message program the request applies to if you have opted into multiple services. Note that Kimberlen Clinical Studies is not liable for any failure to honor unsubscribe requests that do not follow the STOP keyword command. If you unsubscribe from one program, you may still receive texts from other programs unless you opt out separately.
Disclaimer of Warranties
All content, products, and materials provided on our website or any third-party sites are offered “as is” without any warranties, either express or implied. Kimberlen Clinical Studies disclaims all warranties, including but not limited to warranties of title, non-infringement, merchantability, and fitness for a particular purpose. Additionally, Kimberlen Clinical Studies does not guarantee that:
- The website will be error-free or uninterrupted.
- Defects will be corrected.
- The website, emails sent by Kimberlen Clinical Studies, or the server that hosts the website will be free of viruses or other harmful components.
- The website will be available to you or that you will qualify for the products or services offered.
- The materials on the website are accurate as of any particular date.
- The products or services offered through the website are available outside of the United States or in jurisdictions where Kimberlen Clinical Studies is not licensed.
If you reside in a state that does not allow the disclaimer of implied warranties, portions of this disclaimer may not apply to you.
Limitation of Liability
Kimberlen Clinical Studies shall not be liable for any loss, damage, injury, or claim, nor any special, indirect, incidental, consequential, exemplary, or punitive damages of any kind, whether based in tort, contract, negligence, strict liability, or otherwise, even if advised of the possibility of such damages. This includes, but is not limited to:
- The website, materials on the website, or inability to use the website.
- Any third-party site, materials in any third-party site, or inability to use any third-party site.
- Any defect, omission, error, interruption, delay, or computer virus.
- Except as a result of Kimberlen Clinical Studies’ gross negligence or intentional actions, unauthorized alteration of or access to your transmissions or personal data.
If you live in a state that does not permit the limitation of liability for certain damages, the above limitations may not apply to you. However, you agree that Kimberlen Clinical Studies’ total liability for all damages, losses, injuries, or claims of any kind will be limited to the amount you have paid to access the website.
Termination
These Terms and Conditions remain in effect until terminated by either party. You may terminate these terms at any time by discontinuing the use of our website and destroying any materials obtained from it. Kimberlen Clinical Studies reserves the right to terminate these terms and/or the products or services offered at any time without notice if, in our sole judgment, you breach any term or condition. Upon termination, you must cease all use of the website and destroy any materials obtained from Kimberlen Clinical Studies. We reserve the right to terminate all or part of the website at any time without notice.
Entire Agreement
These Terms and Conditions constitute the entire agreement with regard to the subject matter discussed.
Contact Information
For any questions regarding these Terms and Conditions, please contact us:
Kimberlen Clinical Studies Legal Department
150 California St Ste 250 San Francisco, CA 94111 United States
Email: [email protected]